ONTOLOGY,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
BP,GO:0002683,negative regulation of immune system process,26/246,318/12848,4.208452335060015e-10,4.0132245957777014e-7,3.3298005059252176e-7,CD74/RUNX3/FCGR2B/SAMHD1/RNF125/TGFB1/VSIR/LOXL3/GBP1/TNFAIP3/CD274/LRRC17/BST2/IDO1/TRIM21/GPNMB/LYAR/TLR3/COL3A1/CEBPB/PARP14/MAFB/HLA-G/HLA-A/LYN/MILR1,26
BP,GO:0030198,extracellular matrix organization,26/246,318/12848,4.208452335060015e-10,4.0132245957777014e-7,3.3298005059252176e-7,ITGAL/FSCN1/COL5A3/MMP9/TGFB1/SERPINE1/LAMA4/ITGA4/LOXL3/COLGALT1/RAMP2/ETS1/ITGAX/HAPLN1/SERPINH1/ACAN/ADAMTS4/ITGA5/FBLN2/COL1A2/COL3A1/ITGAM/SH3PXD2B/OLFML2A/COL5A2/PECAM1,26
BP,GO:0043062,extracellular structure organization,26/246,319/12848,4.5051451989564734e-10,4.0132245957777014e-7,3.3298005059252176e-7,ITGAL/FSCN1/COL5A3/MMP9/TGFB1/SERPINE1/LAMA4/ITGA4/LOXL3/COLGALT1/RAMP2/ETS1/ITGAX/HAPLN1/SERPINH1/ACAN/ADAMTS4/ITGA5/FBLN2/COL1A2/COL3A1/ITGAM/SH3PXD2B/OLFML2A/COL5A2/PECAM1,26
BP,GO:0045229,external encapsulating structure organization,26/246,321/12848,5.158461380396541e-10,4.0132245957777014e-7,3.3298005059252176e-7,ITGAL/FSCN1/COL5A3/MMP9/TGFB1/SERPINE1/LAMA4/ITGA4/LOXL3/COLGALT1/RAMP2/ETS1/ITGAX/HAPLN1/SERPINH1/ACAN/ADAMTS4/ITGA5/FBLN2/COL1A2/COL3A1/ITGAM/SH3PXD2B/OLFML2A/COL5A2/PECAM1,26
BP,GO:0051607,defense response to virus,21/246,212/12848,6.985595466975981e-10,4.0132245957777014e-7,3.3298005059252176e-7,BIRC3/SAMHD1/RNF125/TLR8/IFIH1/GBP1/TNFAIP3/IFIT3/IFIT2/BST2/TRIM22/OASL/DDX60/PARP9/CXCL9/IFITM3/MX1/DTX3L/TLR3/ISG15/APOBEC3G,21
BP,GO:0140546,defense response to symbiont,21/246,212/12848,6.985595466975981e-10,4.0132245957777014e-7,3.3298005059252176e-7,BIRC3/SAMHD1/RNF125/TLR8/IFIH1/GBP1/TNFAIP3/IFIT3/IFIT2/BST2/TRIM22/OASL/DDX60/PARP9/CXCL9/IFITM3/MX1/DTX3L/TLR3/ISG15/APOBEC3G,21
BP,GO:0009615,response to virus,23/246,287/12848,6.672078250663299e-9,3.2855219614337703e-6,2.726020542413862e-6,BIRC3/ENO1/SAMHD1/RNF125/TLR8/IFIH1/GBP1/TNFAIP3/IFIT3/IFIT2/BST2/TRIM22/OASL/DDX60/IFI44/PARP9/CXCL9/IFITM3/MX1/DTX3L/TLR3/ISG15/APOBEC3G,23
BP,GO:0045765,regulation of angiogenesis,20/246,225/12848,1.1808124713452479e-8,5.087825735908836e-6,4.221404585059261e-6,ALOX5/ANGPT2/PGK1/FLT1/SERPINE1/TNFAIP3/PGF/RAMP2/ETS1/GPNMB/ENPP2/ITGAX/ADM/ITGA5/TLR3/CYBB/PRKCB/THBS2/HLA-G/ECSCR,20
BP,GO:0070661,leukocyte proliferation,21/246,250/12848,1.3704503734332336e-8,5.100529235934181e-6,4.231944767847913e-6,CD38/CD4/CD74/BTN3A1/FCGR2B/MEF2C/VSIR/TCIRG1/TNFAIP3/CD274/CDKN1A/CD70/BST2/IDO1/GPNMB/CEBPB/CARD11/HLA-G/PSMB10/HLA-A/LYN,21
BP,GO:1901342,regulation of vasculature development,20/246,228/12848,1.4797009677789908e-8,5.100529235934181e-6,4.231944767847913e-6,ALOX5/ANGPT2/PGK1/FLT1/SERPINE1/TNFAIP3/PGF/RAMP2/ETS1/GPNMB/ENPP2/ITGAX/ADM/ITGA5/TLR3/CYBB/PRKCB/THBS2/HLA-G/ECSCR,20
BP,GO:0070663,regulation of leukocyte proliferation,18/246,203/12848,6.774273199349998e-8,2.1228108834690403e-5,1.7613110318309994e-5,CD38/CD4/CD74/FCGR2B/MEF2C/VSIR/TNFAIP3/CD274/CDKN1A/CD70/BST2/IDO1/GPNMB/CEBPB/CARD11/HLA-G/HLA-A/LYN,18
BP,GO:0007159,leukocyte cell-cell adhesion,22/246,303/12848,8.487129501953609e-8,2.437927949436174e-5,2.0227658646322766e-5,ITGAL/CD4/ALOX5/CD74/RUNX3/FCGR2B/VSIR/ITGA4/LOXL3/CD274/CD70/IDO1/ETS1/GPNMB/ITGA5/CEBPB/LCK/CARD11/HLA-G/HLA-A/LYN/PECAM1,22
BP,GO:0050727,regulation of inflammatory response,20/246,258/12848,1.1655773999220947e-7,3.0149216743987882e-5,2.501501592335519e-5,ALOX5/BIRC3/CALCRL/FCGR2B/C1QTNF3/MMP9/HCK/TRADD/SERPINE1/TNFAIP3/IDO1/ETS1/TLR2/TNFRSF11A/PLA2G7/TLR3/CEBPB/LACC1/LRRK2/LYN,20
BP,GO:0001525,angiogenesis,26/246,418/12848,1.224511268975429e-7,3.0149216743987882e-5,2.501501592335519e-5,ALOX5/TYMP/CALCRL/ANGPT2/PGK1/FLT1/SERPINE1/TNFAIP3/PGF/RAMP2/ETS1/GPNMB/ANGPTL2/ENPP2/ITGAX/ADM/ITGA5/ESM1/TLR3/CYBB/PRKCB/CSPG4/CLEC14A/THBS2/HLA-G/ECSCR,26
BP,GO:0034341,response to interferon-gamma,16/246,168/12848,1.3853636055318809e-7,3.1835655655122625e-5,2.6414266078807863e-5,CD74/HCK/GBP1/BST2/TRIM21/TRIM22/OASL/TLR2/PARP9/IFITM3/FCGR1A/GBP5/TLR3/PARP14/HLA-G/HLA-A,16
BP,GO:0046651,lymphocyte proliferation,18/246,225/12848,3.2086855976747543e-7,6.912712034490549e-5,5.735525505843623e-5,CD38/CD4/CD74/BTN3A1/FCGR2B/MEF2C/VSIR/CD274/CDKN1A/CD70/IDO1/GPNMB/CEBPB/CARD11/HLA-G/PSMB10/HLA-A/LYN,18
BP,GO:0032943,mononuclear cell proliferation,18/246,227/12848,3.659775512435893e-7,7.420733053745013e-5,6.157034097392148e-5,CD38/CD4/CD74/BTN3A1/FCGR2B/MEF2C/VSIR/CD274/CDKN1A/CD70/IDO1/GPNMB/CEBPB/CARD11/HLA-G/PSMB10/HLA-A/LYN,18
BP,GO:0050670,regulation of lymphocyte proliferation,16/246,186/12848,5.593122876526732e-7,1.0559667219895975e-4,8.761429721178558e-5,CD38/CD4/CD74/FCGR2B/MEF2C/VSIR/CD274/CDKN1A/CD70/IDO1/GPNMB/CEBPB/CARD11/HLA-G/HLA-A/LYN,16
BP,GO:0032944,regulation of mononuclear cell proliferation,16/246,187/12848,6.013229376864356e-7,1.0559667219895975e-4,8.761429721178558e-5,CD38/CD4/CD74/FCGR2B/MEF2C/VSIR/CD274/CDKN1A/CD70/IDO1/GPNMB/CEBPB/CARD11/HLA-G/HLA-A/LYN,16
BP,GO:0031349,positive regulation of defense response,20/246,286/12848,6.126873930894097e-7,1.0559667219895975e-4,8.761429721178558e-5,MEF2C/HCK/TLR8/TRADD/SERPINE1/IDO1/ETS1/TLR2/PARP9/TNFRSF11A/PLA2G7/GJA1/GBP5/TLR3/CEBPB/LRRK2/CARD11/HLA-G/PSMB10/LYN,20
BP,GO:0048514,blood vessel morphogenesis,27/246,491/12848,8.053237589904676e-7,1.3218814272572104e-4,1.0967742622441606e-4,ALOX5/TYMP/CALCRL/ANGPT2/PGK1/FLT1/TGFB1/SERPINE1/TNFAIP3/PGF/RAMP2/ETS1/GPNMB/ANGPTL2/ENPP2/ITGAX/ADM/ITGA5/ESM1/TLR3/CYBB/PRKCB/CSPG4/CLEC14A/THBS2/HLA-G/ECSCR,27
BP,GO:2000147,positive regulation of cell motility,25/246,438/12848,1.0771640036835999e-6,1.6877201457715313e-4,1.4003132047886799e-4,CD74/MMP9/FLT1/TRADD/TGFB1/SERPINE1/VSIR/ITGA4/PGF/CD274/PREX1/ETS1/GPNMB/ENPP2/ITGAX/PLA2G7/ITGA5/MAPRE2/SEMA6B/TCAF2/FAM89B/CAVIN1/FAM110C/LYN/PECAM1,25
BP,GO:0060337,type I interferon signaling pathway,10/246,73/12848,1.1895240806413684e-6,1.7084539608211652e-4,1.4175161960976304e-4,SAMHD1/IFIT3/IFIT2/BST2/OASL/IFITM3/MX1/ISG15/HLA-G/HLA-A,10
BP,GO:0071357,cellular response to type I interferon,10/246,73/12848,1.1895240806413684e-6,1.7084539608211652e-4,1.4175161960976304e-4,SAMHD1/IFIT3/IFIT2/BST2/OASL/IFITM3/MX1/ISG15/HLA-G/HLA-A,10
BP,GO:1903037,regulation of leukocyte cell-cell adhesion,19/246,274/12848,1.3412129001945058e-6,1.8492643467881846e-4,1.5343475578225146e-4,CD4/ALOX5/CD74/RUNX3/FCGR2B/VSIR/ITGA4/LOXL3/CD274/CD70/IDO1/ETS1/GPNMB/CEBPB/LCK/CARD11/HLA-G/HLA-A/LYN,19
BP,GO:0040017,positive regulation of locomotion,25/246,448/12848,1.6234391383332559e-6,2.0717803769186759e-4,1.7189706637619416e-4,CD74/MMP9/FLT1/TRADD/TGFB1/SERPINE1/VSIR/ITGA4/PGF/CD274/PREX1/ETS1/GPNMB/ENPP2/ITGAX/PLA2G7/ITGA5/MAPRE2/SEMA6B/TCAF2/FAM89B/CAVIN1/FAM110C/LYN/PECAM1,25
BP,GO:0051272,positive regulation of cellular component movement,25/246,448/12848,1.6234391383332559e-6,2.0717803769186759e-4,1.7189706637619416e-4,CD74/MMP9/FLT1/TRADD/TGFB1/SERPINE1/VSIR/ITGA4/PGF/CD274/PREX1/ETS1/GPNMB/ENPP2/ITGAX/PLA2G7/ITGA5/MAPRE2/SEMA6B/TCAF2/FAM89B/CAVIN1/FAM110C/LYN/PECAM1,25
BP,GO:0030335,positive regulation of cell migration,24/246,419/12848,1.6829083421445582e-6,2.0717803769186759e-4,1.7189706637619416e-4,CD74/MMP9/FLT1/TRADD/TGFB1/SERPINE1/VSIR/ITGA4/PGF/CD274/PREX1/ETS1/GPNMB/ENPP2/ITGAX/PLA2G7/ITGA5/MAPRE2/SEMA6B/TCAF2/FAM89B/FAM110C/LYN/PECAM1,24
BP,GO:0042110,T cell activation,23/246,394/12848,2.0331435426702354e-6,2.4166364798566557e-4,2.0051001834609907e-4,ITGAL/CD4/CD74/RUNX3/BTN3A1/FCGR2B/APBB1IP/VSIR/TCIRG1/LOXL3/CD274/PREX1/CD70/IDO1/GPNMB/CEBPB/LCK/CARD11/MAFB/HLA-G/PSMB10/HLA-A/LYN,23
BP,GO:0034340,response to type I interferon,10/246,78/12848,2.2153803154609903e-6,2.545471982464678e-4,2.1119959007394773e-4,SAMHD1/IFIT3/IFIT2/BST2/OASL/IFITM3/MX1/ISG15/HLA-G/HLA-A,10
BP,GO:0045785,positive regulation of cell adhesion,22/246,369/12848,2.429737879132877e-6,2.701711764313235e-4,2.241629140103235e-4,CD4/ALOX5/CD74/RUNX3/APBB1IP/VSIR/ITGA4/CD274/PREX1/CD70/ETS1/ITGA5/FBLN2/EDIL3/PLEKHA2/LCK/P4HB/S100A10/CARD11/HLA-G/HLA-A/LYN,22
BP,GO:0002250,adaptive immune response,21/246,342/12848,2.614753432517049e-6,2.8165797130894586e-4,2.3369358803121122e-4,CD4/CD74/BTN3A1/FCGR2B/MEF2C/RNF125/TLR8/IL4I1/TGFB1/TCIRG1/LOXL3/TNFAIP3/CD274/CD70/TNFRSF11A/ERAP2/PRKCB/CD247/HLA-G/HLA-A/LYN,21
BP,GO:0060333,interferon-gamma-mediated signaling pathway,10/246,80/12848,2.8032702119323647e-6,2.9281431577366245e-4,2.4295008503413826e-4,HCK/GBP1/TRIM21/TRIM22/OASL/PARP9/FCGR1A/PARP14/HLA-G/HLA-A,10
BP,GO:0050900,leukocyte migration,22/246,373/12848,2.89743608056375e-6,2.937488873442131e-4,2.4372550560036252e-4,ITGAL/ALOX5/CD74/ANGPT2/MMP9/HCK/FLT1/TGFB1/SERPINE1/ITGA4/PGF/PREX1/CXCL9/ITGAX/TNFRSF11A/PLA2G7/ITGA5/COL1A2/ITGAM/LCK/LYN/PECAM1,22
BP,GO:0002694,regulation of leukocyte activation,24/246,433/12848,2.9837550755568965e-6,2.9385724986984635e-4,2.438154147455064e-4,CD38/CD4/CD74/RUNX3/FCGR2B/MEF2C/TGFB1/VSIR/LOXL3/TNFAIP3/CD274/CDKN1A/CD70/IDO1/GPNMB/ITGAM/CEBPB/LCK/LRRK2/CARD11/HLA-G/HLA-A/LYN/MILR1,24
BP,GO:0051250,negative regulation of lymphocyte activation,12/246,120/12848,3.145457707454253e-6,2.9586196746945206e-4,2.4547874295405655e-4,CD74/RUNX3/FCGR2B/VSIR/LOXL3/TNFAIP3/CD274/IDO1/GPNMB/CEBPB/HLA-G/LYN,12
BP,GO:0002831,regulation of response to biotic stimulus,21/246,347/12848,3.287012672322353e-6,2.9586196746945206e-4,2.4547874295405655e-4,BIRC3/FCGR2B/HCK/SAMHD1/RNF125/TLR8/TNFAIP3/CD274/TRIM21/DDX60/PARP9/LYAR/GBP5/DTX3L/PARP14/CARD11/HLA-G/PSMB10/HLA-A/APOBEC3G/LYN,21
BP,GO:0002695,negative regulation of leukocyte activation,13/246,142/12848,3.2998810494979166e-6,2.9586196746945206e-4,2.4547874295405655e-4,CD74/RUNX3/FCGR2B/VSIR/LOXL3/TNFAIP3/CD274/IDO1/GPNMB/CEBPB/HLA-G/LYN/MILR1,13
BP,GO:0045766,positive regulation of angiogenesis,12/246,121/12848,3.433269132224567e-6,2.9586196746945206e-4,2.4547874295405655e-4,ANGPT2/FLT1/SERPINE1/PGF/RAMP2/ETS1/ITGAX/ADM/ITGA5/TLR3/CYBB/PRKCB,12
BP,GO:1904018,positive regulation of vasculature development,12/246,121/12848,3.433269132224567e-6,2.9586196746945206e-4,2.4547874295405655e-4,ANGPT2/FLT1/SERPINE1/PGF/RAMP2/ETS1/ITGAX/ADM/ITGA5/TLR3/CYBB/PRKCB,12
BP,GO:0043299,leukocyte degranulation,25/246,477/12848,4.9605327672130095e-6,4.170477182581279e-4,3.4602740766412696e-4,ITGAL/ALOX5/FCGR2B/ADA2/PYGL/MMP9/HCK/IMPDH1/TCIRG1/STBD1/BST2/ACLY/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/LYN/PECAM1/MILR1,25
BP,GO:0071346,cellular response to interferon-gamma,13/246,148/12848,5.227519289773414e-6,4.2902997599640375e-4,3.5596917068457057e-4,HCK/GBP1/TRIM21/TRIM22/OASL/TLR2/PARP9/FCGR1A/GBP5/TLR3/PARP14/HLA-G/HLA-A,13
BP,GO:0070664,negative regulation of leukocyte proliferation,9/246,70/12848,7.024360985091439e-6,5.630923794327951e-4,4.672016841246864e-4,FCGR2B/VSIR/TNFAIP3/CD274/IDO1/GPNMB/CEBPB/HLA-G/LYN,9
BP,GO:0007162,negative regulation of cell adhesion,16/246,228/12848,8.061179527747899e-6,6.315201325487956e-4,5.239766693036134e-4,CD74/RUNX3/FCGR2B/ANGPT2/TGFB1/SERPINE1/VSIR/LOXL3/GBP1/CD274/IDO1/PLXNC1/GPNMB/CEBPB/HLA-G/SIPA1,16
BP,GO:0032103,positive regulation of response to external stimulus,22/246,401/12848,9.24477059485781e-6,6.763572000135807e-4,5.611782976613985e-4,CD74/HCK/TLR8/TRADD/TGFB1/SERPINE1/PGF/IDO1/ETS1/TLR2/DDX60/PARP9/TNFRSF11A/PLA2G7/GBP5/TLR3/CEBPB/LRRK2/CARD11/HLA-G/PSMB10/LYN,22
BP,GO:0051249,regulation of lymphocyte activation,21/246,371/12848,9.263425078492299e-6,6.763572000135807e-4,5.611782976613985e-4,CD38/CD4/CD74/RUNX3/FCGR2B/MEF2C/TGFB1/VSIR/LOXL3/TNFAIP3/CD274/CDKN1A/CD70/IDO1/GPNMB/CEBPB/LCK/CARD11/HLA-G/HLA-A/LYN,21
BP,GO:0050866,negative regulation of cell activation,13/246,156/12848,9.313815665082792e-6,6.763572000135807e-4,5.611782976613985e-4,CD74/RUNX3/FCGR2B/VSIR/LOXL3/TNFAIP3/CD274/IDO1/GPNMB/CEBPB/HLA-G/LYN/MILR1,13
BP,GO:0030199,collagen fibril organization,7/246,40/12848,9.418377023687808e-6,6.763572000135807e-4,5.611782976613985e-4,COL5A3/LOXL3/COLGALT1/SERPINH1/COL1A2/COL3A1/COL5A2,7
BP,GO:0050865,regulation of cell activation,24/246,465/12848,1.0023636652296712e-5,7.051321538870769e-4,5.850530780728285e-4,CD38/CD4/CD74/RUNX3/FCGR2B/MEF2C/TGFB1/VSIR/LOXL3/TNFAIP3/CD274/CDKN1A/CD70/IDO1/GPNMB/ITGAM/CEBPB/LCK/LRRK2/CARD11/HLA-G/HLA-A/LYN/MILR1,24
BP,GO:0050868,negative regulation of T cell activation,10/246,93/12848,1.1065272391406274e-5,7.628398786635485e-4,6.329335807884387e-4,CD74/RUNX3/FCGR2B/VSIR/LOXL3/CD274/IDO1/GPNMB/CEBPB/HLA-G,10
BP,GO:1902106,negative regulation of leukocyte differentiation,9/246,76/12848,1.392685394740174e-5,9.412914815038001e-4,7.809961233248818e-4,CD74/RUNX3/FCGR2B/LOXL3/LRRC17/TLR3/MAFB/HLA-G/LYN,9
BP,GO:0001666,response to hypoxia,18/246,294/12848,1.4435582593527647e-5,9.569125615363421e-4,7.939570426440206e-4,CD38/ENO1/MT3/ANGPT2/PGK1/CA9/PGF/RAMP2/ETS1/HILPDA/TLR2/ADM/PDK1/PLOD2/CYBB/P4HB/EIF4EBP1/PSMB10,18
BP,GO:1903707,negative regulation of hemopoiesis,9/246,77/12848,1.5510173539842475e-5,0.0010006158939330847,8.302180030892435e-4,CD74/RUNX3/FCGR2B/LOXL3/LRRC17/TLR3/MAFB/HLA-G/LYN,9
BP,GO:0070482,response to oxygen levels,19/246,325/12848,1.5957110172598993e-5,0.0010006158939330847,8.302180030892435e-4,CD38/ENO1/MT3/ANGPT2/PGK1/CA9/PGF/CDKN1A/RAMP2/ETS1/HILPDA/TLR2/ADM/PDK1/PLOD2/CYBB/P4HB/EIF4EBP1/PSMB10,19
BP,GO:0050777,negative regulation of immune response,11/246,118/12848,1.597140907732034e-5,0.0010006158939330847,8.302180030892435e-4,FCGR2B/SAMHD1/LOXL3/TNFAIP3/TRIM21/LYAR/COL3A1/PARP14/HLA-G/HLA-A/LYN,11
BP,GO:0042119,neutrophil activation,23/246,447/12848,1.6256016843705465e-5,0.0010006158939330847,8.302180030892435e-4,ITGAL/ALOX5/FCGR2B/ADA2/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/PREX1/BST2/ACLY/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/PECAM1,23
BP,GO:0022407,regulation of cell-cell adhesion,20/246,356/12848,1.6982132397376768e-5,0.001026972111820311,8.520859413420623e-4,CD4/ALOX5/CD74/RUNX3/FCGR2B/TGFB1/VSIR/ITGA4/LOXL3/CD274/CD70/IDO1/ETS1/GPNMB/CEBPB/LCK/CARD11/HLA-G/HLA-A/LYN,20
BP,GO:0050729,positive regulation of inflammatory response,10/246,99/12848,1.92995430542829e-5,0.0011337481319696303,9.406787517937752e-4,TRADD/SERPINE1/IDO1/ETS1/TLR2/TNFRSF11A/PLA2G7/TLR3/CEBPB/LRRK2,10
BP,GO:0036230,granulocyte activation,23/246,452/12848,1.940561061392753e-5,0.0011337481319696303,9.406787517937752e-4,ITGAL/ALOX5/FCGR2B/ADA2/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/PREX1/BST2/ACLY/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/PECAM1,23
BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,12/246,144/12848,2.061858357372142e-5,0.0011845376263102956,9.828191503473875e-4,CD4/CD74/TGFB1/ENPP2/PARP9/FCGR1A/NCF1/ITGA5/PARP14/CSPG4/LYN/PECAM1,12
BP,GO:1903900,regulation of viral life cycle,11/246,122/12848,2.190096896942795e-5,0.0012349718153520132,0.0010246647496103157,CD4/CD74/BST2/TRIM21/TRIM22/OASL/IFITM3/MX1/P4HB/ISG15/APOBEC3G,11
BP,GO:0002275,myeloid cell activation involved in immune response,24/246,488/12848,2.221301205448936e-5,0.0012349718153520132,0.0010246647496103157,ITGAL/ALOX5/ADA2/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/BST2/ACLY/DYSF/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/LYN/PECAM1/MILR1,24
BP,GO:0036293,response to decreased oxygen levels,18/246,305/12848,2.3642251848115077e-5,0.0012935689225468678,0.0010732831791366527,CD38/ENO1/MT3/ANGPT2/PGK1/CA9/PGF/RAMP2/ETS1/HILPDA/TLR2/ADM/PDK1/PLOD2/CYBB/P4HB/EIF4EBP1/PSMB10,18
BP,GO:0002444,myeloid leukocyte mediated immunity,24/246,491/12848,2.4537719577637838e-5,0.0013215862403768378,0.0010965293436256908,ITGAL/ALOX5/FCGR2B/ADA2/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/BST2/ACLY/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/LYN/PECAM1/MILR1,24
BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,10/246,103/12848,2.733457522256348e-5,0.0014495735506488664,0.0012027213097927931,CD74/RUNX3/FCGR2B/VSIR/LOXL3/CD274/IDO1/GPNMB/CEBPB/HLA-G,10
BP,GO:0002696,positive regulation of leukocyte activation,17/246,280/12848,2.79040000250657e-5,0.0014549255051415425,0.0012071618638540213,CD38/CD4/CD74/RUNX3/MEF2C/TGFB1/VSIR/CD274/CDKN1A/CD70/ITGAM/LCK/LRRK2/CARD11/HLA-G/HLA-A/LYN,17
BP,GO:0050672,negative regulation of lymphocyte proliferation,8/246,64/12848,2.8279666041335462e-5,0.0014549255051415425,0.0012071618638540213,FCGR2B/VSIR/CD274/IDO1/GPNMB/CEBPB/HLA-G/LYN,8
BP,GO:0032945,negative regulation of mononuclear cell proliferation,8/246,65/12848,3.172209703885685e-5,0.0016080304190138168,0.0013341940813401557,FCGR2B/VSIR/CD274/IDO1/GPNMB/CEBPB/HLA-G/LYN,8
BP,GO:0009617,response to bacterium,23/246,468/12848,3.353784590549851e-5,0.0016674396617103284,0.0013834863453703334,CD4/FCGR2B/MEF2C/PYGL/HCK/TGFB1/SERPINE1/GNLY/TNFAIP3/CD274/IDO1/TLR2/IFI44/CXCL9/TNFRSF11A/HMCN1/ADM/GJA1/TLR3/CEBPB/ISG15/HLA-A/LYN,23
BP,GO:0070665,positive regulation of leukocyte proliferation,11/246,128/12848,3.4338371145939315e-5,0.0016674396617103284,0.0013834863453703334,CD38/CD4/CD74/MEF2C/CD274/CDKN1A/CD70/BST2/CARD11/HLA-A/LYN,11
BP,GO:0042113,B cell activation,14/246,202/12848,3.434529039206072e-5,0.0016674396617103284,0.0013834863453703334,CD38/CD74/FCGR2B/MEF2C/TGFB1/TCIRG1/ITGA4/TNFAIP3/CDKN1A/CD70/BST2/PRKCB/CARD11/LYN,14
BP,GO:0046598,positive regulation of viral entry into host cell,4/246,11/12848,3.893858723768568e-5,0.0018386480850452404,0.0015255391712298773,CD4/CD74/TRIM21/P4HB,4
BP,GO:0075294,positive regulation by symbiont of entry into host,4/246,11/12848,3.893858723768568e-5,0.0018386480850452404,0.0015255391712298773,CD4/CD74/TRIM21/P4HB,4
BP,GO:0042100,B cell proliferation,8/246,67/12848,3.966456858459115e-5,0.0018476184852849419,0.0015329819750260903,CD38/CD74/FCGR2B/MEF2C/CDKN1A/CD70/CARD11/LYN,8
BP,GO:0045088,regulation of innate immune response,16/246,260/12848,4.0934034901344e-5,0.0018813282440657702,0.001560951197571251,BIRC3/FCGR2B/HCK/SAMHD1/TLR8/TNFAIP3/TRIM21/PARP9/LYAR/GBP5/PARP14/CARD11/HLA-G/PSMB10/HLA-A/LYN,16
BP,GO:0050867,positive regulation of cell activation,17/246,289/12848,4.1644773801129715e-5,0.0018888096749012386,0.0015671585930425128,CD38/CD4/CD74/RUNX3/MEF2C/TGFB1/VSIR/CD274/CDKN1A/CD70/ITGAM/LCK/LRRK2/CARD11/HLA-G/HLA-A/LYN,17
BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,14/246,207/12848,4.494558184099968e-5,0.002012044423453583,0.0016694073255228451,CD4/ALOX5/CD74/RUNX3/VSIR/ITGA4/CD274/CD70/ETS1/LCK/CARD11/HLA-G/HLA-A/LYN,14
BP,GO:0046596,regulation of viral entry into host cell,6/246,35/12848,4.722910420344592e-5,0.0020871631049907448,0.0017317338207930167,CD4/CD74/TRIM21/TRIM22/IFITM3/P4HB,6
BP,GO:0006801,superoxide metabolic process,7/246,51/12848,4.8893579039524764e-5,0.0021067020868655232,0.0017479454506630103,MT3/TGFB1/PREX1/NCF1/CYBB/ITGAM/SH3PXD2B,7
BP,GO:0030888,regulation of B cell proliferation,7/246,51/12848,4.8893579039524764e-5,0.0021067020868655232,0.0017479454506630103,CD38/CD74/FCGR2B/MEF2C/CDKN1A/CARD11/LYN,7
BP,GO:1903706,regulation of hemopoiesis,18/246,325/12848,5.447366151269334e-5,0.00231815692881795,0.001923391011435839,CD4/CD74/RUNX3/FCGR2B/MEF2C/TGFB1/VSIR/LOXL3/LRRC17/ETS1/TLR3/PRKCB/CEBPB/ISG15/CARD11/MAFB/HLA-G/LYN,18
BP,GO:0002521,leukocyte differentiation,21/246,420/12848,5.821880281212011e-5,0.0024473196743094883,0.0020305582444227256,CD4/CD74/RUNX3/FCGR2B/MMP9/TGFB1/VSIR/TCIRG1/ITGA4/LOXL3/PREX1/LRRC17/TLR2/TNFRSF11A/TLR3/CEBPB/LCK/CARD11/MAFB/HLA-G/LYN,21
BP,GO:0050851,antigen receptor-mediated signaling pathway,14/246,213/12848,6.13620143117428e-5,0.002548371847380451,0.002114401938934752,CD38/CD4/BTN3A1/FCGR2B/MEF2C/GBP1/BTNL9/PRKCB/LCK/CARD11/CD247/PSMB10/HLA-A/LYN,14
BP,GO:0002507,tolerance induction,5/246,23/12848,6.269799670989539e-5,0.0025728570792739216,0.0021347175070273905,TNFAIP3/CD274/IDO1/HLA-G/LYN,5
BP,GO:0007229,integrin-mediated signaling pathway,9/246,92/12848,6.511311107931323e-5,0.0026405281634163847,0.0021908646786686567,ITGAL/HCK/ITGA4/LOXL3/ITGAX/ITGA5/COL3A1/ITGAM/ISG15,9
BP,GO:0045824,negative regulation of innate immune response,7/246,54/12848,7.12311894889577e-5,0.002855045467074851,0.0023688511853304536,SAMHD1/TNFAIP3/TRIM21/LYAR/PARP14/HLA-G/HLA-A,7
BP,GO:0002573,myeloid leukocyte differentiation,12/246,166/12848,8.3557476673052e-5,0.0032729843419546617,0.0027156179918741896,CD4/CD74/MMP9/TGFB1/TCIRG1/LRRC17/TLR2/TNFRSF11A/TLR3/CEBPB/MAFB/LYN,12
BP,GO:0042098,T cell proliferation,12/246,166/12848,8.3557476673052e-5,0.0032729843419546617,0.0027156179918741896,CD4/BTN3A1/VSIR/CD274/CD70/IDO1/GPNMB/CEBPB/CARD11/HLA-G/PSMB10/HLA-A,12
BP,GO:0031348,negative regulation of defense response,12/246,168/12848,9.3741642090163e-5,0.0035184167985198803,0.0029192550170486966,ALOX5/CALCRL/FCGR2B/C1QTNF3/SAMHD1/RNF125/TNFAIP3/TRIM21/LYAR/PARP14/HLA-G/HLA-A,12
BP,GO:0022408,negative regulation of cell-cell adhesion,11/246,143/12848,9.47371377370315e-5,0.0035184167985198803,0.0029192550170486966,CD74/RUNX3/FCGR2B/TGFB1/VSIR/LOXL3/CD274/IDO1/GPNMB/CEBPB/HLA-G,11
BP,GO:0043312,neutrophil degranulation,21/246,435/12848,9.588647653277561e-5,0.0035184167985198803,0.0029192550170486966,ITGAL/ALOX5/ADA2/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/BST2/ACLY/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/PECAM1,21
BP,GO:0006735,"NADH regeneration",5/246,25/12848,9.594754251838374e-5,0.0035184167985198803,0.0029192550170486966,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0061621,canonical glycolysis,5/246,25/12848,9.594754251838374e-5,0.0035184167985198803,0.0029192550170486966,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0061718,glucose catabolic process to pyruvate,5/246,25/12848,9.594754251838374e-5,0.0035184167985198803,0.0029192550170486966,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0050863,regulation of T cell activation,16/246,280/12848,9.870233228283772e-5,0.0035598441798097686,0.0029536276049480525,CD4/CD74/RUNX3/FCGR2B/VSIR/LOXL3/CD274/CD70/IDO1/GPNMB/CEBPB/LCK/CARD11/HLA-G/HLA-A/LYN,16
BP,GO:0051251,positive regulation of lymphocyte activation,15/246,251/12848,9.91427447814731e-5,0.0035598441798097686,0.0029536276049480525,CD38/CD4/CD74/RUNX3/MEF2C/TGFB1/VSIR/CD274/CDKN1A/CD70/LCK/CARD11/HLA-G/HLA-A/LYN,15
BP,GO:2000351,regulation of endothelial cell apoptotic process,6/246,40/12848,1.0309714896417068e-4,0.0036636687884484156,0.0030397716086343106,SERPINE1/ITGA4/TNFAIP3/RAMP2/HLA-G/ECSCR,6
BP,GO:0002283,neutrophil activation involved in immune response,21/246,438/12848,1.0561004639576725e-4,0.0037146717339409155,0.0030820891091009623,ITGAL/ALOX5/ADA2/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/BST2/ACLY/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/PECAM1,21
BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,18/246,343/12848,1.085409156470207e-4,0.003742117749768828,0.0031048612603245857,CD38/CD4/BTN3A1/FCGR2B/MEF2C/HCK/WIPF1/GBP1/FCGR1A/BTNL9/PRKCB/LCK/CARD11/CD247/HLA-G/PSMB10/HLA-A/LYN,18
BP,GO:0042116,macrophage activation,8/246,77/12848,1.0856158252883168e-4,0.003742117749768828,0.0031048612603245857,CD74/FCGR2B/TLR8/DYSF/TLR2/TLR3/ITGAM/LRRK2,8
BP,GO:0061620,glycolytic process through glucose-6-phosphate,5/246,26/12848,1.169495352651103e-4,0.003991337109493418,0.0033116403055268857,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0002764,immune response-regulating signaling pathway,18/246,346/12848,1.2112311144107906e-4,0.004060214719842539,0.003368788540397349,CD38/CD4/BTN3A1/FCGR2B/MEF2C/HCK/WIPF1/GBP1/FCGR1A/BTNL9/PRKCB/LCK/CARD11/CD247/HLA-G/PSMB10/HLA-A/LYN,18
BP,GO:1902105,regulation of leukocyte differentiation,14/246,227/12848,1.2132350337794648e-4,0.004060214719842539,0.003368788540397349,CD4/CD74/RUNX3/FCGR2B/TGFB1/VSIR/LOXL3/LRRC17/TLR3/CEBPB/CARD11/MAFB/HLA-G/LYN,14
BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,17/246,316/12848,1.2520474339673942e-4,0.004110292861795817,0.003410338724901664,CD38/CD4/BTN3A1/FCGR2B/MEF2C/HCK/WIPF1/GBP1/FCGR1A/BTNL9/PRKCB/LCK/CARD11/CD247/PSMB10/HLA-A/LYN,17
BP,GO:0002757,immune response-activating signal transduction,17/246,316/12848,1.2520474339673942e-4,0.004110292861795817,0.003410338724901664,CD38/CD4/BTN3A1/FCGR2B/MEF2C/HCK/WIPF1/GBP1/FCGR1A/BTNL9/PRKCB/LCK/CARD11/CD247/PSMB10/HLA-A/LYN,17
BP,GO:0052372,modulation by symbiont of entry into host,6/246,42/12848,1.3646607137763836e-4,0.004437722151308674,0.0036820090956608082,CD4/CD74/TRIM21/TRIM22/IFITM3/P4HB,6
BP,GO:0002446,neutrophil mediated immunity,21/246,447/12848,1.4024364556013952e-4,0.004509938298162505,0.0037419273376108966,ITGAL/ALOX5/ADA2/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/BST2/ACLY/TLR2/GLIPR1/ITGAX/DSN1/FABP5/CYBB/RAB31/ITGAM/PGAM1/PLEKHO2/PECAM1,21
BP,GO:0061615,glycolytic process through fructose-6-phosphate,5/246,27/12848,1.4130354981188004e-4,0.004509938298162505,0.0037419273376108966,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0044275,cellular carbohydrate catabolic process,6/246,43/12848,1.5608186726084623e-4,0.00493591005915722,0.004095359085926791,PHKA2/PYGL/TPI1/STBD1/PGM2L1/PGAM1,6
BP,GO:0032102,negative regulation of response to external stimulus,16/246,292/12848,1.6045108588015874e-4,0.005027953572990065,0.004171728232884127,ALOX5/CALCRL/FCGR2B/C1QTNF3/ANGPT2/SAMHD1/RNF125/SERPINE1/TNFAIP3/TRIM21/LYAR/GJA1/SEMA6B/PARP14/HLA-G/HLA-A,16
BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,14/246,234/12848,1.6694960264594465e-4,0.005184461984870011,0.0043015843564630785,CD4/CD74/BIRC3/TLR8/TRADD/TNFAIP3/BST2/TRIM21/TRIM22/TLR2/GJA1/TLR3/PRKCB/CARD11,14
BP,GO:0050864,regulation of B cell activation,9/246,104/12848,1.6879362378311363e-4,0.005194925189110649,0.004310265750175937,CD38/CD74/FCGR2B/MEF2C/TGFB1/TNFAIP3/CDKN1A/CARD11/LYN,9
BP,GO:0072577,endothelial cell apoptotic process,6/246,44/12848,1.7786266102298213e-4,0.0054255981641258355,0.004501656730316185,SERPINE1/ITGA4/TNFAIP3/RAMP2/HLA-G/ECSCR,6
BP,GO:0048010,vascular endothelial growth factor receptor signaling pathway,8/246,84/12848,2.0050226677387442e-4,0.006062555382188992,0.0050301445874849195,MT3/FLT1/PGF/NCF1/ITGA5/CYBB/PRKCB/CLEC14A,8
BP,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,11/246,156/12848,2.0521446973588325e-4,0.0061510806711268665,0.005103594638648922,CD4/CD74/BIRC3/TRADD/BST2/TRIM21/TRIM22/GJA1/TLR3/PRKCB/CARD11,11
BP,GO:0006909,phagocytosis,14/246,239/12848,2.0800635772231878e-4,0.006181016509214076,0.005128432612808894,ITGAL/FCGR2B/HCK/WIPF1/DYSF/TLR2/LYAR/FCGR1A/RAB31/ITGAM/RAB39A/CD247/LYN/PECAM1,14
BP,GO:0050792,regulation of viral process,11/246,157/12848,2.1701182384156078e-4,0.006344445565948452,0.005264030843809856,CD4/CD74/BST2/TRIM21/TRIM22/OASL/IFITM3/MX1/P4HB/ISG15/APOBEC3G,11
BP,GO:0022409,positive regulation of cell-cell adhesion,14/246,240/12848,2.1718728656278425e-4,0.006344445565948452,0.005264030843809856,CD4/ALOX5/CD74/RUNX3/VSIR/ITGA4/CD274/CD70/ETS1/LCK/CARD11/HLA-G/HLA-A/LYN,14
BP,GO:1903530,regulation of secretion by cell,20/246,429/12848,2.2414298432833107e-4,0.0064926123275609844,0.005386965841840561,CD38/ALOX5/FCGR2B/MEF2C/C1QTNF3/ITPR3/TGFB1/TCIRG1/P3H1/RHBDF2/TLR2/TNFRSF11A/GJA1/RAB3C/PRKCB/ITGAM/SEPTIN1/SEPTIN5/LRRK2/LYN,20
BP,GO:0019674,"NAD metabolic process",6/246,46/12848,2.285934292001533e-4,0.006512078929363045,0.0054031174174581685,CD38/ENO1/PGK1/TPI1/PGM2L1/PGAM1,6
BP,GO:0045071,negative regulation of viral genome replication,6/246,46/12848,2.285934292001533e-4,0.006512078929363045,0.0054031174174581685,BST2/OASL/IFITM3/MX1/ISG15/APOBEC3G,6
BP,GO:0002832,negative regulation of response to biotic stimulus,8/246,86/12848,2.3615919825987954e-4,0.006672465216408237,0.005536191041174225,SAMHD1/RNF125/TNFAIP3/TRIM21/LYAR/PARP14/HLA-G/HLA-A,8
BP,GO:0001818,negative regulation of cytokine production,14/246,243/12848,2.4685637966009676e-4,0.006917999517791492,0.005739912567706315,FCGR2B/C1QTNF3/RNF125/TLR8/TGFB1/VSIR/IFIH1/GBP1/TNFAIP3/CD274/BST2/IDO1/GPNMB/ISG15,14
BP,GO:0051046,regulation of secretion,21/246,467/12848,2.552575729496208e-4,0.007073252408867277,0.005868726976895971,CD38/ALOX5/CD74/FCGR2B/MEF2C/C1QTNF3/ITPR3/TGFB1/TCIRG1/P3H1/RHBDF2/TLR2/TNFRSF11A/GJA1/RAB3C/PRKCB/ITGAM/SEPTIN1/SEPTIN5/LRRK2/LYN,21
BP,GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",4/246,17/12848,2.5650030493426447e-4,0.007073252408867277,0.005868726976895971,RUNX3/VSIR/CD274/HLA-A,4
BP,GO:0030099,myeloid cell differentiation,17/246,338/12848,2.783996231553109e-4,0.007616218262034577,0.006319229541461819,CD4/CD74/MEF2C/MMP9/TGFB1/TCIRG1/LRRC17/ETS1/TLR2/TNFRSF11A/LYAR/TLR3/PRKCB/CEBPB/ISG15/MAFB/LYN,17
BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,13/246,218/12848,2.9397949925519473e-4,0.007979112865611466,0.006620325731258716,CD4/CD74/FCGR2B/MEF2C/TLR8/TGFB1/TCIRG1/LOXL3/TNFAIP3/CD274/CD70/HLA-G/HLA-A,13
BP,GO:0002237,response to molecule of bacterial origin,15/246,279/12848,3.1478392124916784e-4,0.0084770326292647,0.007033453240411094,FCGR2B/MEF2C/HCK/TGFB1/SERPINE1/TNFAIP3/CD274/IDO1/TLR2/CXCL9/TNFRSF11A/ADM/GJA1/CEBPB/LYN,15
BP,GO:0007565,female pregnancy,10/246,138/12848,3.1952166094728585e-4,0.008537916009963523,0.007083968607048353,CD38/ANGPT2/MMP9/APOL2/IDO1/RAMP2/ETS1/ADM/GJA1/ITGA5,10
BP,GO:0035455,response to interferon-alpha,4/246,18/12848,3.248531023168637e-4,0.008578416441064975,0.007117572097895511,IFIT3/IFIT2/BST2/IFITM3,4
BP,GO:0030890,positive regulation of B cell proliferation,5/246,32/12848,3.260146660224867e-4,0.008578416441064975,0.007117572097895511,CD38/CD74/MEF2C/CDKN1A/CARD11,5
BP,GO:0071219,cellular response to molecule of bacterial origin,11/246,165/12848,3.337961018717056e-4,0.008716630023877039,0.007232248873886955,FCGR2B/MEF2C/HCK/TGFB1/SERPINE1/TNFAIP3/CD274/TLR2/CXCL9/CEBPB/LYN,11
BP,GO:0043903,regulation of biological process involved in symbiotic interaction,11/246,166/12848,3.5155497204709344e-4,0.00908537726970661,0.007538201041880159,CD4/CD74/BST2/TRIM21/TRIM22/OASL/IFITM3/MX1/P4HB/ISG15/APOBEC3G,11
BP,GO:0001819,positive regulation of cytokine production,17/246,345/12848,3.531884404237557e-4,0.00908537726970661,0.007538201041880159,CD4/CD74/C1QTNF3/TLR8/TGFB1/SERPINE1/IFIH1/CD274/IDO1/HILPDA/TLR2/GBP5/TLR3/CEBPB/CARD11/HLA-G/HLA-A,17
BP,GO:0018108,peptidyl-tyrosine phosphorylation,15/246,283/12848,3.6619522036963247e-4,0.009350184626771283,0.0077579135574603626,CD4/CD74/HCK/FLT1/TGFB1/ENPP2/PARP9/FCGR1A/NCF1/ITGA5/PARP14/CSPG4/LCK/LYN/PECAM1,15
BP,GO:0002761,regulation of myeloid leukocyte differentiation,8/246,92/12848,3.7548266253621866e-4,0.009494788126148571,0.007877892091901628,CD4/CD74/TGFB1/LRRC17/TLR3/CEBPB/MAFB/LYN,8
BP,GO:0006007,glucose catabolic process,5/246,33/12848,3.7828939143732285e-4,0.009494788126148571,0.007877892091901628,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0018212,peptidyl-tyrosine modification,15/246,284/12848,3.8012206597287575e-4,0.009494788126148571,0.007877892091901628,CD4/CD74/HCK/FLT1/TGFB1/ENPP2/PARP9/FCGR1A/NCF1/ITGA5/PARP14/CSPG4/LCK/LYN/PECAM1,15
BP,GO:0045637,regulation of myeloid cell differentiation,12/246,196/12848,3.94725156229417e-4,0.009788615924624464,0.008121683070619659,CD4/CD74/MEF2C/TGFB1/LRRC17/ETS1/TLR3/PRKCB/CEBPB/ISG15/MAFB/LYN,12
BP,GO:0042129,regulation of T cell proliferation,10/246,142/12848,4.0167202386638326e-4,0.009889739044767308,0.008205585630413258,CD4/VSIR/CD274/CD70/IDO1/GPNMB/CEBPB/CARD11/HLA-G/HLA-A,10
BP,GO:0032946,positive regulation of mononuclear cell proliferation,9/246,117/12848,4.092448961962069e-4,0.009934275754847361,0.008242538050148955,CD38/CD4/CD74/MEF2C/CD274/CDKN1A/CD70/CARD11/HLA-A,9
BP,GO:0050671,positive regulation of lymphocyte proliferation,9/246,117/12848,4.092448961962069e-4,0.009934275754847361,0.008242538050148955,CD38/CD4/CD74/MEF2C/CD274/CDKN1A/CD70/CARD11/HLA-A,9
BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,12/246,198/12848,4.3266971136287843e-4,0.01038036101093497,0.00861265810596867,CD4/CD74/TGFB1/ENPP2/PARP9/FCGR1A/NCF1/ITGA5/PARP14/CSPG4/LYN/PECAM1,12
BP,GO:0070169,positive regulation of biomineral tissue development,5/246,34/12848,4.366557431347753e-4,0.01038036101093497,0.00861265810596867,ALOX5/MEF2C/TGFB1/CEBPB/ISG15,5
BP,GO:0110151,positive regulation of biomineralization,5/246,34/12848,4.366557431347753e-4,0.01038036101093497,0.00861265810596867,ALOX5/MEF2C/TGFB1/CEBPB/ISG15,5
BP,GO:0048525,negative regulation of viral process,7/246,72/12848,4.4247920842822283e-4,0.010446752270219755,0.008667743397977516,BST2/TRIM21/OASL/IFITM3/MX1/ISG15/APOBEC3G,7
BP,GO:0032613,interleukin-10 production,6/246,52/12848,4.5151451821698156e-4,0.01051601719117524,0.008725212987165994,FCGR2B/VSIR/CD274/IDO1/TLR2/ISG15,6
BP,GO:0042130,negative regulation of T cell proliferation,6/246,52/12848,4.5151451821698156e-4,0.01051601719117524,0.008725212987165994,VSIR/CD274/IDO1/GPNMB/CEBPB/HLA-G,6
BP,GO:0032693,negative regulation of interleukin-10 production,4/246,20/12848,4.990921515253458e-4,0.01152585300434411,0.009563080821707036,FCGR2B/VSIR/CD274/IDO1,4
BP,GO:0001774,microglial cell activation,5/246,35/12848,5.015601829566627e-4,0.01152585300434411,0.009563080821707036,TLR8/TLR2/TLR3/ITGAM/LRRK2,5
BP,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,12/246,203/12848,5.412325580504546e-4,0.012355156474171637,0.010251159708770198,CD4/CD74/BIRC3/TRADD/TNFAIP3/BST2/TRIM21/TRIM22/GJA1/TLR3/PRKCB/CARD11,12
BP,GO:0050853,B cell receptor signaling pathway,6/246,54/12848,5.548452694246628e-4,0.012582576603334296,0.01043985177996405,CD38/FCGR2B/MEF2C/PRKCB/LCK/LYN,6
BP,GO:0034599,cellular response to oxidative stress,13/246,234/12848,5.782859479043201e-4,0.013028442238079684,0.010809789614420624,ALOX5/GUCY1B1/MT3/MMP9/TNFAIP3/ETS1/PDK1/NCF1/GPX8/CYBB/PYCR1/P4HB/LRRK2,13
BP,GO:0032496,response to lipopolysaccharide,14/246,265/12848,5.914910843080273e-4,0.013239414075388119,0.010984834422863363,MEF2C/HCK/TGFB1/SERPINE1/TNFAIP3/CD274/IDO1/TLR2/CXCL9/TNFRSF11A/ADM/GJA1/CEBPB/LYN,14
BP,GO:2000108,positive regulation of leukocyte apoptotic process,4/246,21/12848,6.07320370773196e-4,0.013506021406807784,0.011206040389750581,MEF2C/CD274/IDO1/LYN,4
BP,GO:0001501,skeletal system development,17/246,363/12848,6.301612783531578e-4,0.013924140554380352,0.01155295676980789,RUNX3/MEF2C/MMP9/TGFB1/P3H1/RUNX2/LRRC17/HAPLN3/HAPLN1/SERPINH1/GJA1/ACAN/ADAMTS4/COL1A2/COL3A1/SH3PXD2B/COL5A2,17
BP,GO:0042060,wound healing,19/246,433/12848,6.767072135901182e-4,0.014857387039777945,0.012327277903616164,ALOX5/ITPR3/TGFB1/TFPI2/SERPINE1/TNFAIP3/CDKN1A/ETS1/DYSF/MYOF/GJA1/ITGA5/COL1A2/PRKCB/COL3A1/LCK/F8/LYN/ANXA8,19
BP,GO:0002221,pattern recognition receptor signaling pathway,11/246,180/12848,6.963890859062472e-4,0.015192741639992622,0.012605523960075107,BIRC3/RNF125/TLR8/IFIH1/TNFAIP3/TLR2/DDX60/TLR3/ITGAM/LACC1/LYN,11
BP,GO:0002367,cytokine production involved in immune response,7/246,78/12848,7.201768085383373e-4,0.015612889679444332,0.012954123725909714,CD74/TGFB1/BST2/TLR3/LACC1/HLA-G/HLA-A,7
BP,GO:0005980,glycogen catabolic process,4/246,22/12848,7.312044301094832e-4,0.01575288544117118,0.013070279188207013,PHKA2/PYGL/STBD1/PGM2L1,4
BP,GO:0031589,cell-substrate adhesion,15/246,305/12848,7.974383212305343e-4,0.01700098293063089,0.014105834401393775,ITGAL/COL5A3/SIGLEC1/ANGPT2/SERPINE1/ITGA4/GBP1/PREX1/ITGA5/FBLN2/EDIL3/COL3A1/PLEKHA2/P4HB/S100A10,15
BP,GO:0044706,multi-multicellular organism process,10/246,155/12848,7.990018087502768e-4,0.01700098293063089,0.014105834401393775,CD38/ANGPT2/MMP9/APOL2/IDO1/RAMP2/ETS1/ADM/GJA1/ITGA5,10
BP,GO:0050854,regulation of antigen receptor-mediated signaling pathway,6/246,58/12848,8.159302964169472e-4,0.01725467320091544,0.014316322992346435,FCGR2B/GBP1/PRKCB/LCK/CARD11/LYN,6
BP,GO:0002697,regulation of immune effector process,16/246,339/12848,8.349844020899025e-4,0.017462514461952943,0.014488770339769485,CD74/FCGR2B/RNF125/TGFB1/LOXL3/TNFAIP3/BST2/DDX60/PARP9/DTX3L/TLR3/ITGAM/HLA-G/HLA-A/APOBEC3G/LYN,16
BP,GO:0006734,"NADH metabolic process",5/246,39/12848,8.358905965251626e-4,0.017462514461952943,0.014488770339769485,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0097190,apoptotic signaling pathway,20/246,477/12848,8.63923749502366e-4,0.017574320715716504,0.014581536770220246,CD38/CD74/ENO1/MMP9/TRADD/TGFB1/SERPINE1/TNFAIP3/CDKN1A/CD70/YWHAH/PDK1/TLR3/ITGAM/CEBPB/PHLDA3/LCK/P4HB/LRRK2/CRIP1,20
BP,GO:0001782,B cell homeostasis,4/246,23/12848,8.719426266146604e-4,0.017574320715716504,0.014581536770220246,CD74/MEF2C/TNFAIP3/LYN,4
BP,GO:0009251,glucan catabolic process,4/246,23/12848,8.719426266146604e-4,0.017574320715716504,0.014581536770220246,PHKA2/PYGL/STBD1/PGM2L1,4
BP,GO:0036037,"CD8-positive, alpha-beta T cell activation",4/246,23/12848,8.719426266146604e-4,0.017574320715716504,0.014581536770220246,RUNX3/VSIR/CD274/HLA-A,4
BP,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",4/246,23/12848,8.719426266146604e-4,0.017574320715716504,0.014581536770220246,RUNX3/VSIR/LOXL3/CD274,4
BP,GO:0071216,cellular response to biotic stimulus,11/246,185/12848,8.73416836164982e-4,0.017574320715716504,0.014581536770220246,FCGR2B/MEF2C/HCK/TGFB1/SERPINE1/TNFAIP3/CD274/TLR2/CXCL9/CEBPB/LYN,11
BP,GO:0048771,tissue remodeling,9/246,130/12848,8.803405889438538e-4,0.017574320715716504,0.014581536770220246,CD38/MEF2C/TGFB1/TCIRG1/TNFAIP3/GPNMB/TNFRSF11A/GJA1/CSPG4,9
BP,GO:0071222,cellular response to lipopolysaccharide,10/246,157/12848,8.820300214154207e-4,0.017574320715716504,0.014581536770220246,MEF2C/HCK/TGFB1/SERPINE1/TNFAIP3/CD274/TLR2/CXCL9/CEBPB/LYN,10
BP,GO:0016525,negative regulation of angiogenesis,7/246,82/12848,9.715242291177535e-4,0.01913625153010798,0.015877481687295854,ALOX5/ANGPT2/PGK1/SERPINE1/THBS2/HLA-G/ECSCR,7
BP,GO:2000181,negative regulation of blood vessel morphogenesis,7/246,82/12848,9.715242291177535e-4,0.01913625153010798,0.015877481687295854,ALOX5/ANGPT2/PGK1/SERPINE1/THBS2/HLA-G/ECSCR,7
BP,GO:0050870,positive regulation of T cell activation,11/246,188/12848,9.964809339364224e-4,0.019516305564084364,0.016192815176466865,CD4/CD74/RUNX3/VSIR/CD274/CD70/LCK/CARD11/HLA-G/HLA-A/LYN,11
BP,GO:0002645,positive regulation of tolerance induction,3/246,11/12848,0.0010211262254438466,0.019738624296325013,0.016377274582967664,CD274/IDO1/HLA-G,3
BP,GO:2001198,regulation of dendritic cell differentiation,3/246,11/12848,0.0010211262254438466,0.019738624296325013,0.016377274582967664,FCGR2B/CEBPB/HLA-G,3
BP,GO:0019883,antigen processing and presentation of endogenous antigen,4/246,24/12848,0.001030737561165797,0.019738624296325013,0.016377274582967664,CD74/ERAP2/HLA-G/HLA-A,4
BP,GO:0044247,cellular polysaccharide catabolic process,4/246,24/12848,0.001030737561165797,0.019738624296325013,0.016377274582967664,PHKA2/PYGL/STBD1/PGM2L1,4
BP,GO:1901343,negative regulation of vasculature development,7/246,83/12848,0.0010440218087794386,0.019882558977142126,0.01649669819397345,ALOX5/ANGPT2/PGK1/SERPINE1/THBS2/HLA-G/ECSCR,7
BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,9/246,134/12848,0.0010920253842285242,0.020682480766130343,0.017160398895019666,CD4/FCGR2B/MEF2C/TGFB1/LOXL3/TNFAIP3/CD274/HLA-G/HLA-A,9
BP,GO:0062207,regulation of pattern recognition receptor signaling pathway,7/246,84/12848,0.0011207054035072173,0.02110968046934086,0.017514849475577274,BIRC3/RNF125/TNFAIP3/TLR2/DDX60/TLR3/LYN,7
BP,GO:0000272,polysaccharide catabolic process,4/246,25/12848,0.001208792802812923,0.022522750223222403,0.01868728332997275,PHKA2/PYGL/STBD1/PGM2L1,4
BP,GO:0060055,angiogenesis involved in wound healing,4/246,25/12848,0.001208792802812923,0.022522750223222403,0.01868728332997275,ALOX5/SERPINE1/TNFAIP3/ETS1,4
BP,GO:0043068,positive regulation of programmed cell death,19/246,455/12848,0.001216979359068875,0.02255337554145383,0.01871269337062894,MEF2C/MMP9/TRADD/ITGA4/IFIT2/CD274/PREX1/CDKN1A/IDO1/ADM/TLR3/ITGAM/PHLDA3/LCK/LRRK2/HLA-G/PNMA2/ECSCR/LYN,19
BP,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,6/246,63/12848,0.001265130614948438,0.02332034882207094,0.019349056463917283,BIRC3/RNF125/IFIH1/TNFAIP3/DDX60/LACC1,6
BP,GO:0002253,activation of immune response,17/246,387/12848,0.0012752066206739349,0.02338104905033539,0.01939941986769922,CD38/CD4/BTN3A1/FCGR2B/MEF2C/HCK/WIPF1/GBP1/FCGR1A/BTNL9/PRKCB/LCK/CARD11/CD247/PSMB10/HLA-A/LYN,17
BP,GO:0032675,regulation of interleukin-6 production,8/246,111/12848,0.0013055808639681993,0.02381130813808668,0.019756408841000262,CD74/C1QTNF3/TLR8/IFIH1/TNFAIP3/TLR2/TLR3/CEBPB,8
BP,GO:0000727,double-strand break repair via break-induced replication,3/246,12/12848,0.0013423246133218102,0.024113957876046463,0.020007519444587434,MCM2/MCM5/GINS2,3
BP,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,3/246,12/12848,0.0013423246133218102,0.024113957876046463,0.020007519444587434,MT3/ITGA5/PRKCB,3
BP,GO:0051099,positive regulation of binding,9/246,138/12848,0.0013431621445317437,0.024113957876046463,0.020007519444587434,MMP9/TGFB1/RAMP2/TRIM21/DERL1/PARP9/DTX3L/LRRK2/S100A10,9
BP,GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",6/246,64/12848,0.0013740323631448673,0.024540360392540712,0.020361308593752958,FCGR1A/NCF1/CYBB/HLA-G/PSMB10/HLA-A,6
BP,GO:0043552,positive regulation of phosphatidylinositol 3-kinase activity,4/246,26/12848,0.0014073097605488887,0.02500513785882484,0.020746937707060934,FLT1/TGFB1/AGAP2/LYN,4
BP,GO:0009117,nucleotide metabolic process,19/246,462/12848,0.0014524115446670567,0.025509077816931628,0.021165060213642135,TYMP/GUCY1B1/ENO1/SCD/SAMHD1/PGK1/TGFB1/NUDT1/IMPDH1/TPI1/IDO1/ACLY/PARP9/PDK1/PGM2L1/PGAM1/LACC1/LRRK2/CARD11,19
BP,GO:0006968,cellular defense response,5/246,44/12848,0.0014589320603643075,0.025509077816931628,0.021165060213642135,TCIRG1/GNLY/CXCL9/NCF1/HLA-G,5
BP,GO:0072521,purine-containing compound metabolic process,17/246,392/12848,0.0014639256166491964,0.025509077816931628,0.021165060213642135,GUCY1B1/ENO1/ADA2/SCD/SAMHD1/PGK1/TGFB1/NUDT1/IMPDH1/TPI1/ACLY/PDK1/PGM2L1/PGAM1/LACC1/LRRK2/CARD11,17
BP,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,7/246,88/12848,0.0014726737701100648,0.025509077816931628,0.021165060213642135,FCGR1A/NCF1/ERAP2/CYBB/HLA-G/PSMB10/HLA-A,7
BP,GO:0032609,interferon-gamma production,7/246,88/12848,0.0014726737701100648,0.025509077816931628,0.021165060213642135,BTN3A1/TLR8/VSIR/CD274/TLR3/ISG15/HLA-A,7
BP,GO:0032479,regulation of type I interferon production,8/246,114/12848,0.0015496362601593635,0.02670798094384663,0.022159798520278898,RNF125/TLR8/IFIH1/TNFAIP3/TRIM21/TLR2/TLR3/ISG15,8
BP,GO:0006979,response to oxidative stress,16/246,360/12848,0.0015633460370889308,0.026768469815129457,0.022209986559695458,CD38/ALOX5/GUCY1B1/MT3/PTGS1/MMP9/NUDT1/TNFAIP3/ETS1/PDK1/NCF1/GPX8/CYBB/PYCR1/P4HB/LRRK2,16
BP,GO:0019882,antigen processing and presentation,11/246,199/12848,0.0015767244768256096,0.026768469815129457,0.022209986559695458,CD74/FCGR2B/RAB32/FCGR1A/RAB3C/NCF1/ERAP2/CYBB/HLA-G/PSMB10/HLA-A,11
BP,GO:1903131,mononuclear cell differentiation,15/246,327/12848,0.0016005008395731668,0.026768469815129457,0.022209986559695458,CD4/CD74/RUNX3/FCGR2B/VSIR/TCIRG1/ITGA4/LOXL3/PREX1/CEBPB/LCK/CARD11/MAFB/HLA-G/LYN,15
BP,GO:0050871,positive regulation of B cell activation,6/246,66/12848,0.0016131601388574552,0.026768469815129457,0.022209986559695458,CD38/CD74/MEF2C/TGFB1/CDKN1A/CARD11,6
BP,GO:1904035,regulation of epithelial cell apoptotic process,6/246,66/12848,0.0016131601388574552,0.026768469815129457,0.022209986559695458,SERPINE1/ITGA4/TNFAIP3/RAMP2/HLA-G/ECSCR,6
BP,GO:0002548,monocyte chemotaxis,5/246,45/12848,0.0016160516603323364,0.026768469815129457,0.022209986559695458,FLT1/SERPINE1/TNFRSF11A/PLA2G7/LYN,5
BP,GO:0042554,superoxide anion generation,4/246,27/12848,0.001627484753720546,0.026768469815129457,0.022209986559695458,TGFB1/NCF1/CYBB/ITGAM,4
BP,GO:0045730,respiratory burst,4/246,27/12848,0.001627484753720546,0.026768469815129457,0.022209986559695458,HCK/NCF1/CYBB/PGAM1,4
BP,GO:0050690,regulation of defense response to virus by virus,4/246,27/12848,0.001627484753720546,0.026768469815129457,0.022209986559695458,CD4/HCK/LCK/CD247,4
BP,GO:0032606,type I interferon production,8/246,115/12848,0.0016385689384950147,0.026768469815129457,0.022209986559695458,RNF125/TLR8/IFIH1/TNFAIP3/TRIM21/TLR2/TLR3/ISG15,8
BP,GO:0032635,interleukin-6 production,8/246,115/12848,0.0016385689384950147,0.026768469815129457,0.022209986559695458,CD74/C1QTNF3/TLR8/IFIH1/TNFAIP3/TLR2/TLR3/CEBPB,8
BP,GO:0097529,myeloid leukocyte migration,10/246,171/12848,0.0016836054309022606,0.027374471322264587,0.022712790247077664,CD74/FLT1/SERPINE1/PGF/PREX1/CXCL9/TNFRSF11A/PLA2G7/LYN/PECAM1,10
BP,GO:0010935,regulation of macrophage cytokine production,3/246,13/12848,0.0017204659001912952,0.02766543612267414,0.02295420577628315,CD74/TGFB1/HLA-G,3
BP,GO:0070206,protein trimerization,3/246,13/12848,0.0017204659001912952,0.02766543612267414,0.02295420577628315,CD74/COL1A2/HLA-G,3
BP,GO:0006753,nucleoside phosphate metabolic process,19/246,469/12848,0.0017255784062590483,0.02766543612267414,0.02295420577628315,TYMP/GUCY1B1/ENO1/SCD/SAMHD1/PGK1/TGFB1/NUDT1/IMPDH1/TPI1/IDO1/ACLY/PARP9/PDK1/PGM2L1/PGAM1/LACC1/LRRK2/CARD11,19
BP,GO:0022617,extracellular matrix disassembly,6/246,67/12848,0.0017439713361212309,0.02783087590560131,0.023091472320864444,FSCN1/MMP9/TGFB1/ETS1/ADAMTS4/SH3PXD2B,6
BP,GO:0032757,positive regulation of interleukin-8 production,5/246,46/12848,0.0017852538836411376,0.028228303380325694,0.02342122067529199,CD74/TLR8/SERPINE1/TLR2/TLR3,5
BP,GO:0060760,positive regulation of response to cytokine stimulus,5/246,46/12848,0.0017852538836411376,0.028228303380325694,0.02342122067529199,CD74/IFIH1/TLR2/PARP9/PARP14,5
BP,GO:0046718,viral entry into host cell,8/246,117/12848,0.0018285416709554426,0.02875719677120741,0.02386004721951064,CD4/CD74/SIGLEC1/TRIM21/TRIM22/IFITM3/ITGA5/P4HB,8
BP,GO:0071456,cellular response to hypoxia,10/246,173/12848,0.0018353882476546649,0.02875719677120741,0.02386004721951064,ENO1/MT3/PGK1/CA9/HILPDA/PDK1/CYBB/P4HB/EIF4EBP1/PSMB10,10
BP,GO:0052548,regulation of endopeptidase activity,15/246,332/12848,0.00185605983458537,0.028949494343057783,0.02401959785934008,BIRC3/LXN/MT3/MMP9/TRADD/TFPI2/SERPINE1/VSIR/BST2/SERPINH1/SERPINB8/LCK/LYN/ANXA8L1/ANXA8,15
BP,GO:0071276,cellular response to cadmium ion,4/246,28/12848,0.0018705062726343937,0.029043401449417812,0.024097513242046693,MT3/MMP9/NCF1/CYBB,4
BP,GO:0060759,regulation of response to cytokine stimulus,9/246,146/12848,0.001984800636365467,0.030679855576465312,0.025455290672669217,CD74/BIRC3/SAMHD1/TRADD/IFIH1/TNFAIP3/TLR2/PARP9/PARP14,9
BP,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,6/246,69/12848,0.002029580288859068,0.031231978820076823,0.025913391188111316,FCGR1A/NCF1/CYBB/HLA-G/PSMB10/HLA-A,6
BP,GO:0046636,negative regulation of alpha-beta T cell activation,4/246,29/12848,0.0021375524212058693,0.031913749994751155,0.026479061498401013,RUNX3/VSIR/LOXL3/CD274,4
BP,GO:1903902,positive regulation of viral life cycle,4/246,29/12848,0.0021375524212058693,0.031913749994751155,0.026479061498401013,CD4/CD74/TRIM21/P4HB,4
BP,GO:0030217,T cell differentiation,11/246,207/12848,0.0021527523200730782,0.031913749994751155,0.026479061498401013,CD4/CD74/RUNX3/VSIR/TCIRG1/LOXL3/PREX1/LCK/CARD11/MAFB/HLA-G,11
BP,GO:0010934,macrophage cytokine production,3/246,14/12848,0.002158899275517193,0.031913749994751155,0.026479061498401013,CD74/TGFB1/HLA-G,3
BP,GO:0002260,lymphocyte homeostasis,5/246,48/12848,0.0021620826710866494,0.031913749994751155,0.026479061498401013,CD74/MEF2C/TCIRG1/TNFAIP3/LYN,5
BP,GO:0030595,leukocyte chemotaxis,10/246,177/12848,0.002172168714063939,0.031913749994751155,0.026479061498401013,ALOX5/CD74/FLT1/SERPINE1/PGF/PREX1/CXCL9/TNFRSF11A/PLA2G7/LYN,10
BP,GO:0002819,regulation of adaptive immune response,9/246,148/12848,0.002178359511128243,0.031913749994751155,0.026479061498401013,CD4/FCGR2B/MEF2C/TGFB1/LOXL3/TNFAIP3/CD274/HLA-G/HLA-A,9
BP,GO:0071674,mononuclear cell migration,9/246,148/12848,0.002178359511128243,0.031913749994751155,0.026479061498401013,ITGAL/ALOX5/FLT1/SERPINE1/ITGA4/TNFRSF11A/PLA2G7/LYN/PECAM1,9
BP,GO:0006112,energy reserve metabolic process,6/246,70/12848,0.00218498549427365,0.031913749994751155,0.026479061498401013,PHKA2/MT3/PYGL/PCDH12/STBD1/PGM2L1,6
BP,GO:0009144,purine nucleoside triphosphate metabolic process,6/246,70/12848,0.00218498549427365,0.031913749994751155,0.026479061498401013,ENO1/SAMHD1/TGFB1/NUDT1/IMPDH1/LRRK2,6
BP,GO:0032092,positive regulation of protein binding,6/246,70/12848,0.00218498549427365,0.031913749994751155,0.026479061498401013,MMP9/RAMP2/TRIM21/DERL1/DTX3L/LRRK2,6
BP,GO:0046849,bone remodeling,6/246,70/12848,0.00218498549427365,0.031913749994751155,0.026479061498401013,CD38/TGFB1/TCIRG1/TNFAIP3/TNFRSF11A/GJA1,6
BP,GO:0034614,cellular response to reactive oxygen species,8/246,121/12848,0.0022604801259691895,0.032877109680235425,0.027278367764860263,GUCY1B1/MT3/MMP9/TNFAIP3/ETS1/NCF1/PYCR1/LRRK2,8
BP,GO:0019320,hexose catabolic process,5/246,49/12848,0.0023708054245085665,0.034336833186054745,0.02848951056342227,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0030308,negative regulation of cell growth,9/246,150/12848,0.0023866724615341957,0.03442200826321495,0.028560180920451043,ENO1/MT3/TGFB1/CDKN2C/CDKN1A/BST2/GJA1/SEMA6B/SIPA1,9
BP,GO:0006163,purine nucleotide metabolic process,16/246,376/12848,0.002426332753721278,0.03446700031262103,0.028597511138409092,GUCY1B1/ENO1/SCD/SAMHD1/PGK1/TGFB1/NUDT1/IMPDH1/TPI1/ACLY/PDK1/PGM2L1/PGAM1/LACC1/LRRK2/CARD11,16
BP,GO:0030501,positive regulation of bone mineralization,4/246,30/12848,0.0024297885337879054,0.03446700031262103,0.028597511138409092,ALOX5/MEF2C/TGFB1/ISG15,4
BP,GO:0039528,cytoplasmic pattern recognition receptor signaling pathway in response to virus,4/246,30/12848,0.0024297885337879054,0.03446700031262103,0.028597511138409092,BIRC3/RNF125/IFIH1/DDX60,4
BP,GO:0090218,positive regulation of lipid kinase activity,4/246,30/12848,0.0024297885337879054,0.03446700031262103,0.028597511138409092,FLT1/TGFB1/AGAP2/LYN,4
BP,GO:0036294,cellular response to decreased oxygen levels,10/246,180/12848,0.0024560632308183246,0.03469692605176543,0.02878828213172299,ENO1/MT3/PGK1/CA9/HILPDA/PDK1/CYBB/P4HB/EIF4EBP1/PSMB10,10
BP,GO:0002718,regulation of cytokine production involved in immune response,6/246,72/12848,0.0025225399488644795,0.035346321966405934,0.02932709046240817,CD74/TGFB1/BST2/TLR3/HLA-G/HLA-A,6
BP,GO:0045069,regulation of viral genome replication,6/246,72/12848,0.0025225399488644795,0.035346321966405934,0.02932709046240817,BST2/OASL/IFITM3/MX1/ISG15/APOBEC3G,6
BP,GO:0046686,response to cadmium ion,5/246,50/12848,0.0025938017984199722,0.036197711737464146,0.030033494508020734,MT3/MMP9/NUDT1/NCF1/CYBB,5
BP,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,3/246,15/12848,0.0026607199913384312,0.03668600724057429,0.03043863670091165,ERAP2/HLA-G/HLA-A,3
BP,GO:0034134,toll-like receptor 2 signaling pathway,3/246,15/12848,0.0026607199913384312,0.03668600724057429,0.03043863670091165,TNFAIP3/TLR2/LYN,3
BP,GO:2000353,positive regulation of endothelial cell apoptotic process,3/246,15/12848,0.0026607199913384312,0.03668600724057429,0.03043863670091165,ITGA4/HLA-G/ECSCR,3
BP,GO:0030316,osteoclast differentiation,6/246,73/12848,0.0027053148447194085,0.037152271991027094,0.03082549982429286,TCIRG1/LRRC17/TNFRSF11A/TLR3/CEBPB/MAFB,6
BP,GO:0062197,cellular response to chemical stress,13/246,278/12848,0.0027379915246361418,0.037445114672998554,0.031068473444959634,ALOX5/GUCY1B1/MT3/MMP9/TNFAIP3/ETS1/PDK1/NCF1/GPX8/CYBB/PYCR1/P4HB/LRRK2,13
BP,GO:0032570,response to progesterone,4/246,31/12848,0.002748364958592583,0.037445114672998554,0.031068473444959634,CD38/TGFB1/RAMP2/TLR2,4
BP,GO:0032653,regulation of interleukin-10 production,5/246,51/12848,0.002831624748609674,0.038427600426998214,0.03188364874418766,FCGR2B/VSIR/CD274/IDO1/TLR2,5
BP,GO:0010810,regulation of cell-substrate adhesion,10/246,184/12848,0.0028801491500619354,0.03886717634387036,0.032248367955749695,ANGPT2/SERPINE1/GBP1/PREX1/ITGA5/FBLN2/EDIL3/PLEKHA2/P4HB/S100A10,10
BP,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,6/246,74/12848,0.0028978428547649206,0.03886717634387036,0.032248367955749695,FCGR2B/HCK/WIPF1/FCGR1A/CD247/LYN,6
BP,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,6/246,74/12848,0.0028978428547649206,0.03886717634387036,0.032248367955749695,FCGR2B/HCK/WIPF1/FCGR1A/CD247/LYN,6
BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,8/246,127/12848,0.003054313663243559,0.04063584160123477,0.03371584188556177,TRADD/TRIM21/TRIM22/TLR2/TNFRSF11A/TLR3/PRKCB/CARD11,8
BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,5/246,52/12848,0.0030848279646089,0.04063584160123477,0.03371584188556177,HCK/TGFB1/TNFAIP3/TLR2/LYN,5
BP,GO:0032615,interleukin-12 production,5/246,52/12848,0.0030848279646089,0.04063584160123477,0.03371584188556177,TLR8/IDO1/TLR2/TLR3/HLA-G,5
BP,GO:0032655,regulation of interleukin-12 production,5/246,52/12848,0.0030848279646089,0.04063584160123477,0.03371584188556177,TLR8/IDO1/TLR2/TLR3/HLA-G,5
BP,GO:0032728,positive regulation of interferon-beta production,4/246,32/12848,0.003094415000388314,0.04063584160123477,0.03371584188556177,TLR8/IFIH1/TLR2/TLR3,4
BP,GO:0038094,Fc-gamma receptor signaling pathway,6/246,75/12848,0.003100442802763198,0.04063584160123477,0.03371584188556177,FCGR2B/HCK/WIPF1/FCGR1A/CD247/LYN,6
BP,GO:0048872,homeostasis of number of cells,11/246,218/12848,0.0032129919177905798,0.04184061583766345,0.034715451492810405,CD74/MEF2C/TCIRG1/TNFAIP3/ETS1/LYAR/FSTL1/ISG15/CARD11/MAFB/LYN,11
BP,GO:0010715,regulation of extracellular matrix disassembly,3/246,16/12848,0.0032287797542264224,0.04184061583766345,0.034715451492810405,FSCN1/TGFB1/ETS1,3
BP,GO:0071800,podosome assembly,3/246,16/12848,0.0032287797542264224,0.04184061583766345,0.034715451492810405,FSCN1/HCK/SH3PXD2B,3
BP,GO:0002440,production of molecular mediator of immune response,9/246,157/12848,0.0032434171952044444,0.041872880418987714,0.03474222164151577,CD74/FCGR2B/SAMHD1/TGFB1/BST2/TLR3/LACC1/HLA-G/HLA-A,9
BP,GO:0052547,regulation of peptidase activity,15/246,353/12848,0.003331320927651587,0.04284725088662321,0.035550663630908724,BIRC3/LXN/MT3/MMP9/TRADD/TFPI2/SERPINE1/VSIR/BST2/SERPINH1/SERPINB8/LCK/LYN/ANXA8L1/ANXA8,15
BP,GO:0046365,monosaccharide catabolic process,5/246,53/12848,0.003353965213875027,0.042924970391259885,0.03561514804728844,ENO1/PGK1/TPI1/PGM2L1/PGAM1,5
BP,GO:0044409,entry into host,8/246,129/12848,0.0033622692212475105,0.042924970391259885,0.03561514804728844,CD4/CD74/SIGLEC1/TRIM21/TRIM22/IFITM3/ITGA5/P4HB,8
BP,GO:0002431,Fc receptor mediated stimulatory signaling pathway,6/246,77/12848,0.003537143424748245,0.04482549038642353,0.03719202277492639,FCGR2B/HCK/WIPF1/FCGR1A/CD247/LYN,6
BP,GO:0032963,collagen metabolic process,6/246,77/12848,0.003537143424748245,0.04482549038642353,0.03719202277492639,MMP9/TGFB1/VSIR/P3H1/SERPINH1/COL1A2,6
BP,GO:0019724,B cell mediated immunity,7/246,103/12848,0.0036112685292301575,0.045591648322240164,0.03782770937093324,CD74/FCGR2B/TLR8/TGFB1/TCIRG1/CD70/HLA-G,7
BP,GO:0010951,negative regulation of endopeptidase activity,10/246,190/12848,0.0036240532753971004,0.045591648322240164,0.03782770937093324,LXN/MT3/MMP9/TFPI2/SERPINE1/BST2/SERPINH1/SERPINB8/ANXA8L1/ANXA8,10
BP,GO:1901136,carbohydrate derivative catabolic process,9/246,160/12848,0.0036775715688438216,0.046096687992016924,0.03824674431597574,TYMP/ADA2/SAMHD1/TGFB1/NUDT1/ACAN/CSPG4/APOBEC3G/FBXO17,9
BP,GO:0030098,lymphocyte differentiation,13/246,288/12848,0.0037025202182584174,0.046241257943249146,0.038366695015286494,CD4/CD74/RUNX3/FCGR2B/VSIR/TCIRG1/ITGA4/LOXL3/PREX1/LCK/CARD11/MAFB/HLA-G,13
BP,GO:0071453,cellular response to oxygen levels,10/246,191/12848,0.0037616503680558905,0.04681014013967023,0.03883870055104638,ENO1/MT3/PGK1/CA9/HILPDA/PDK1/CYBB/P4HB/EIF4EBP1/PSMB10,10
BP,GO:0006898,receptor-mediated endocytosis,11/246,223/12848,0.003816834217134293,0.04701237862844911,0.039006499239154176,CALCRL/FCGR2B/SIGLEC1/SERPINE1/ITGA4/RAMP2/ADM/FCGR1A/MX1/RAB31/ITGAM,11
BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,3/246,17/12848,0.0038656967790747458,0.04701237862844911,0.039006499239154176,ERAP2/HLA-G/HLA-A,3
BP,GO:0002544,chronic inflammatory response,3/246,17/12848,0.0038656967790747458,0.04701237862844911,0.039006499239154176,TNFAIP3/IDO1/GJA1,3
BP,GO:0002643,regulation of tolerance induction,3/246,17/12848,0.0038656967790747458,0.04701237862844911,0.039006499239154176,CD274/IDO1/HLA-G,3
BP,GO:0039535,regulation of RIG-I signaling pathway,3/246,17/12848,0.0038656967790747458,0.04701237862844911,0.039006499239154176,BIRC3/RNF125/DDX60,3
BP,GO:0061042,vascular wound healing,3/246,17/12848,0.0038656967790747458,0.04701237862844911,0.039006499239154176,ALOX5/SERPINE1/TNFAIP3,3
BP,GO:0032735,positive regulation of interleukin-12 production,4/246,34/12848,0.003873372651720205,0.04701237862844911,0.039006499239154176,IDO1/TLR2/TLR3/HLA-G,4
BP,GO:0070265,necrotic cell death,5/246,55/12848,0.003942253421716385,0.047680517700548694,0.03956085889862758,BIRC3/MT3/PYGL/IPMK/TLR3,5
BP,GO:0072593,reactive oxygen species metabolic process,11/246,225/12848,0.004082414750397471,0.04920308966650378,0.04082414750397471,ALOX5/MT3/TGFB1/PREX1/CDKN1A/TLR2/NCF1/CYBB/ITGAM/SH3PXD2B/LRRK2,11
BP,GO:0048002,antigen processing and presentation of peptide antigen,9/246,163/12848,0.004156092466899891,0.049916553078062455,0.04141611308478637,CD74/FCGR2B/FCGR1A/NCF1/ERAP2/CYBB/HLA-G/PSMB10/HLA-A,9
CC,GO:0031012,extracellular matrix,33/254,448/13331,2.3722554888830197e-11,4.369033485799448e-9,3.7375017230257685e-9,COL5A3/ANGPT2/MMP9/TGFB1/TFPI2/SERPINE1/LAMA4/P3H1/COL21A1/LRRC17/EMILIN2/ANGPTL2/HAPLN3/HMCN1/HAPLN1/SERPINH1/SPARCL1/ACAN/ADAMTS4/FBLN2/EDIL3/TLR3/COL1A2/SERPINB8/COL3A1/CSPG4/CLEC14A/MXRA7/OLFML2A/THBS2/S100A10/COL5A2/ANXA8,33
CC,GO:0030312,external encapsulating structure,33/254,449/13331,2.518174919769134e-11,4.369033485799448e-9,3.7375017230257685e-9,COL5A3/ANGPT2/MMP9/TGFB1/TFPI2/SERPINE1/LAMA4/P3H1/COL21A1/LRRC17/EMILIN2/ANGPTL2/HAPLN3/HMCN1/HAPLN1/SERPINH1/SPARCL1/ACAN/ADAMTS4/FBLN2/EDIL3/TLR3/COL1A2/SERPINB8/COL3A1/CSPG4/CLEC14A/MXRA7/OLFML2A/THBS2/S100A10/COL5A2/ANXA8,33
CC,GO:0062023,collagen-containing extracellular matrix,28/254,349/13331,1.2242326319656177e-10,1.4160290776402311e-8,1.2113459726817693e-8,COL5A3/ANGPT2/MMP9/TGFB1/SERPINE1/LAMA4/P3H1/COL21A1/EMILIN2/ANGPTL2/HMCN1/HAPLN1/SERPINH1/SPARCL1/ACAN/ADAMTS4/FBLN2/EDIL3/COL1A2/SERPINB8/COL3A1/CSPG4/CLEC14A/MXRA7/THBS2/S100A10/COL5A2/ANXA8,28
CC,GO:0045121,membrane raft,19/254,274/13331,1.2643494228306103e-6,8.774584994444436e-5,7.50624288922594e-5,CD4/HCK/PGK1/TRADD/BST2/TLR2/MYOF/EFHD2/SERPINH1/GJA1/ITGAM/CAVIN1/LCK/LRRK2/S100A10/CARD11/LYN/PECAM1/FXYD1,19
CC,GO:0098857,membrane microdomain,19/254,274/13331,1.2643494228306103e-6,8.774584994444436e-5,7.50624288922594e-5,CD4/HCK/PGK1/TRADD/BST2/TLR2/MYOF/EFHD2/SERPINH1/GJA1/ITGAM/CAVIN1/LCK/LRRK2/S100A10/CARD11/LYN/PECAM1/FXYD1,19
CC,GO:0005788,endoplasmic reticulum lumen,17/254,253/13331,7.0763308765572334e-6,3.737362424780242e-4,3.1971369749371405e-4,CD4/RCN1/COL5A3/P3H1/COL21A1/COLGALT1/POGLUT2/SERPINH1/SPARCL1/FSTL1/GPX8/ERAP2/COL1A2/COL3A1/F8/P4HB/COL5A2,17
CC,GO:0008305,integrin complex,6/254,26/13331,7.539347830968788e-6,3.737362424780242e-4,3.1971369749371405e-4,ITGAL/ITGA4/ITGAX/ITGA5/ITGAM/LYN,6
CC,GO:0098802,plasma membrane signaling receptor complex,12/254,138/13331,1.284217236412096e-5,5.570292262937467e-4,4.7651218508975153e-4,ITGAL/CD4/CALCRL/APBB1IP/ITGA4/RAMP2/TLR2/ITGAX/ITGA5/ITGAM/CD247/LYN,12
CC,GO:0098636,protein complex involved in cell adhesion,6/254,30/13331,1.8240191881665296e-5,7.032607314375398e-4,6.0160632872861e-4,ITGAL/ITGA4/ITGAX/ITGA5/ITGAM/LYN,6
CC,GO:0045335,phagocytic vesicle,11/254,122/13331,2.1040319459746578e-5,7.300990852532063e-4,6.245652723840565e-4,TCIRG1/GNLY/RAB32/TLR2/NCF1/CYBB/RAB31/RAB39A/FMNL1/HLA-G/HLA-A,11
CC,GO:0043235,receptor complex,18/254,306/13331,2.3393948287746692e-5,7.379727323498275e-4,6.313008054683798e-4,ITGAL/CD4/CD74/CALCRL/APBB1IP/ITPR3/FLT1/TRADD/NT5DC3/ITGA4/RAMP2/PLXNC1/TLR2/ITGAX/ITGA5/ITGAM/CD247/LYN,18
CC,GO:0005583,fibrillar collagen trimer,4/254,11/13331,3.822950720907131e-5,9.523532971700564e-4,8.146932498163384e-4,COL5A3/COL1A2/COL3A1/COL5A2,4
CC,GO:0098643,banded collagen fibril,4/254,11/13331,3.822950720907131e-5,9.523532971700564e-4,8.146932498163384e-4,COL5A3/COL1A2/COL3A1/COL5A2,4
CC,GO:0030670,phagocytic vesicle membrane,8/254,67/13331,3.8423475966515246e-5,9.523532971700564e-4,8.146932498163384e-4,TCIRG1/RAB32/TLR2/CYBB/RAB31/RAB39A/HLA-G/HLA-A,8
CC,GO:0098797,plasma membrane protein complex,20/254,418/13331,1.5044572424481847e-4,0.003480311087530134,0.002977241700844829,ITGAL/CD4/CD74/CALCRL/APBB1IP/TRADD/ITGA4/RAMP2/TLR2/ITGAX/GJA1/NCF1/ITGA5/CYBB/ITGAM/CD247/HLA-G/HLA-A/LYN/FXYD1,20
CC,GO:0030666,endocytic vesicle membrane,10/254,130/13331,1.8981359812362026e-4,0.004116582409306014,0.0035215417546619024,CD74/TCIRG1/RAB32/TLR2/FCGR1A/CYBB/RAB31/RAB39A/HLA-G/HLA-A,10
CC,GO:0098552,side of membrane,20/254,437/13331,2.7048727107496773e-4,0.005521122533118459,0.004723059470163524,CD4/CD74/BTN3A1/ANK1/FCGR2B/HCK/TLR8/CD274/CXCL9/TNFRSF11A/ITGA5/BTNL9/ITGAM/CLEC14A/LCK/P4HB/LRRK2/HLA-G/HLA-A/LYN,20
CC,GO:0005769,early endosome,16/254,316/13331,3.7240961886534404e-4,0.0071792298747930215,0.006141491960235499,CD4/SIGLEC1/RAB32/CD274/DYSF/GPNMB/DERL1/DIAPH2/FCGR1A/GJA1/DTX3L/TLR3/RAB31/SAMD9L/HLA-G/HLA-A,16
CC,GO:0098644,complex of collagen trimers,4/254,19/13331,3.981601136181996e-4,0.00727166102239554,0.006220562439907607,COL5A3/COL1A2/COL3A1/COL5A2,4
CC,GO:0030139,endocytic vesicle,14/254,259/13331,4.5134031449275524e-4,0.007830754456449304,0.006698840457208262,CD74/TCIRG1/GNLY/RAB32/DYSF/TLR2/FCGR1A/NCF1/CYBB/RAB31/RAB39A/FMNL1/HLA-G/HLA-A,14
CC,GO:0009897,external side of plasma membrane,14/254,261/13331,4.873787158728565e-4,0.007985718479562259,0.006831404857383761,CD4/CD74/BTN3A1/FCGR2B/TLR8/CD274/CXCL9/TNFRSF11A/ITGA5/BTNL9/ITGAM/CLEC14A/P4HB/HLA-G,14
CC,GO:0030667,secretory granule membrane,14/254,262/13331,5.062991543238319e-4,0.007985718479562259,0.006831404857383761,CD38/ITGAL/ITPR3/TCIRG1/STBD1/BST2/TLR2/GLIPR1/ITGAX/FABP5/CYBB/RAB31/ITGAM/PECAM1,14
CC,GO:0005581,collagen trimer,7/254,78/13331,7.010431072242839e-4,0.010576606878557673,0.00904778747081227,COL5A3/C1QTNF3/COL21A1/EMILIN2/COL1A2/COL3A1/COL5A2,7
CC,GO:0071162,CMG complex,3/254,10/13331,7.428790545818321e-4,0.010740792997495656,0.009188240938248977,MCM2/MCM5/GINS2,3
CC,GO:0101002,ficolin-1-rich granule,10/254,166/13331,0.0013039260619123112,0.01767032264613401,0.015116126152615778,ALOX5/PYGL/MMP9/IMPDH1/TCIRG1/STBD1/ACLY/ITGAX/PGAM1/PLEKHO2,10
CC,GO:0031261,DNA replication preinitiation complex,3/254,12/13331,0.0013240011204596086,0.01767032264613401,0.015116126152615778,MCM2/MCM5/GINS2,3
CC,GO:0042101,T cell receptor complex,3/254,17/13331,0.0038141460076757156,0.04901883943198049,0.04193330113701957,CD4/APBB1IP/CD247,3
MF,GO:0005201,extracellular matrix structural constituent,15/249,140/13063,6.862111513624952e-8,3.259502968971852e-5,2.86041700988998e-5,CD4/COL5A3/TFPI2/LAMA4/COL21A1/EMILIN2/HMCN1/HAPLN1/ACAN/FBLN2/EDIL3/COL1A2/COL3A1/THBS2/COL5A2,15
MF,GO:0005178,integrin binding,11/249,121/13063,1.948634171289094e-5,0.004628006156811598,0.004061363851739375,ITGA4/GPNMB/ITGAX/ITGA5/EDIL3/ESM1/COL3A1/ITGAM/P4HB/ISG15/LYN,11
MF,GO:0005525,GTP binding,16/249,309/13063,2.904918477968257e-4,0.021767429942297734,0.01910227647013829,GUCY1B1/SAMHD1/RASL12/GIMAP2/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,16
MF,GO:0032550,purine ribonucleoside binding,16/249,313/13063,3.3525273399177537e-4,0.021767429942297734,0.01910227647013829,GUCY1B1/SAMHD1/RASL12/GIMAP2/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,16
MF,GO:0001883,purine nucleoside binding,16/249,316/13063,3.7262337645155687e-4,0.021767429942297734,0.01910227647013829,GUCY1B1/SAMHD1/RASL12/GIMAP2/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,16
MF,GO:0032549,ribonucleoside binding,16/249,316/13063,3.7262337645155687e-4,0.021767429942297734,0.01910227647013829,GUCY1B1/SAMHD1/RASL12/GIMAP2/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,16
MF,GO:0003924,GTPase activity,14/249,256/13063,4.019169946826644e-4,0.021767429942297734,0.01910227647013829,RASL12/NUDT1/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,14
MF,GO:0019001,guanyl nucleotide binding,16/249,321/13063,4.429118236066578e-4,0.021767429942297734,0.01910227647013829,GUCY1B1/SAMHD1/RASL12/GIMAP2/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,16
MF,GO:0032561,guanyl ribonucleotide binding,16/249,321/13063,4.429118236066578e-4,0.021767429942297734,0.01910227647013829,GUCY1B1/SAMHD1/RASL12/GIMAP2/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,16
MF,GO:0001882,nucleoside binding,16/249,322/13063,4.582616829957418e-4,0.021767429942297734,0.01910227647013829,GUCY1B1/SAMHD1/RASL12/GIMAP2/GBP1/RAB32/AGAP2/RAB3C/GBP5/MX1/RAB31/TUBB6/RAB39A/SEPTIN1/SEPTIN5/LRRK2,16
MF,GO:0030020,extracellular matrix structural constituent conferring tensile strength,5/249,39/13063,8.196397987470813e-4,0.03338957321189856,0.029301431561023442,COL5A3/COL21A1/COL1A2/COL3A1/COL5A2,5
MF,GO:0005539,glycosaminoglycan binding,11/249,185/13063,8.435260600900688e-4,0.03338957321189856,0.029301431561023442,LXN/COL5A3/ADA2/PGF/GPNMB/TLR2/HAPLN3/HAPLN1/ACAN/FSTL1/THBS2,11
MF,GO:0005172,vascular endothelial growth factor receptor binding,3/249,12/13063,0.0013253544700097353,0.046981393810075746,0.04122910127155678,CCDC88A/PGF/ITGA5,3
MF,GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",4/249,26/13063,0.0013847147649285482,0.046981393810075746,0.04122910127155678,NCF1/PLEKHA2/PHLDA3/ANXA8,4
